Emergent Biosolutions
EBS
EBS
272 hedge funds and large institutions have $2.21B invested in Emergent Biosolutions in 2018 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 98 increasing their positions, 79 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 238 → 272 (+34)
12.49% less ownership
Funds ownership: 97.58% → 85.09% (-12%)
Holders
272
Holding in Top 10
4
Calls
$1.36M
Puts
–
Top Buyers
| 1 | +$29.5M | |
| 2 | +$17.9M | |
| 3 | +$16.8M | |
| 4 |
Renaissance Technologies
New York
|
+$14.9M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$13.4M |
Top Sellers
| 1 | -$34.7M | |
| 2 | -$28M | |
| 3 | -$23.1M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$13.6M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$9.66M |